Question 1

FDA가 Johnson & Johnson에게 판매를 승인한 것은 무엇입니까?

Accepted Answer

The FDA granted De Novo marketing authorization for the OTTAVA Robotic Surgical System, cleared for ten general surgery procedures in the upper abdomen, including cholecystectomy, appendectomy, gastric sleeve, and Roux-en-Y gastric bypass.

Question 2

OTTAVA가 다른 수술용 로봇과 다른 점은 무엇입니까?

Accepted Answer

According to Johnson & Johnson, OTTAVA integrates its four robotic arms directly into the operating table rather than using carts or booms, a design the company says occupies 30 to 50 percent less space than traditional systems.

Question 3

병원은 언제 OTTAVA를 사용할 수 있습니까?

Accepted Answer

Johnson & Johnson said it will launch the system commercially with select US customers first, while pursuing additional approved uses and clearance in other countries; a US clinical trial for inguinal hernia repair is ongoing.

Johnson & Johnson

존슨앤존슨, FDA로부터 로봇 수술 장치 승인 획득

날카로운 한 줄.
매일.

Johnson & Johnson

존슨앤존슨, FDA로부터 로봇 수술 장치 승인 획득

날카로운 한 줄.매일.

날카로운 한 줄.
매일.